CYTEK BIOSCIENCES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
CYTEK BIOSCIENCES, INC. (CTKB) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $1.08M, a 85.45% decline year-over-year.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $1.09M, a 1.11% increase year-over-year.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was -$4.09M, a 349.60% decline year-over-year.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $5.04M, a 85.49% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.72M.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00.
- CYTEK BIOSCIENCES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.08M 10-Q · filed 2026-08-05 | $2.17M derived: sum of 3 quarters · filed 2026-08-05 | -$1.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $1.09M derived: sum of 2 quarters · filed 2026-05-07 | -$3.00M derived: sum of 3 quarters · filed 2026-05-07 | $4.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.00M derived: sum of 2 quarters · filed 2026-02-26 | $4.44M derived: sum of 3 quarters · filed 2026-08-05 | $5.04M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.35M derived: sum of 2 quarters · filed 2026-08-05 | $3.95M 10-Q · filed 2025-11-05 | $5.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.03M 10-Q · filed 2026-08-05 | $9.11M derived: sum of 3 quarters · filed 2026-08-05 | $10.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $599.00K 10-Q · filed 2026-05-07 | $1.68M derived: sum of 2 quarters · filed 2026-05-07 | $3.31M derived: sum of 3 quarters · filed 2026-05-07 | $3.31M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.72M derived: sum of 2 quarters · filed 2026-02-26 | $2.72M derived: sum of 3 quarters · filed 2026-02-26 | $2.72M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.64M derived: sum of 2 quarters · filed 2025-11-05 | $1.64M 10-Q · filed 2025-11-05 | $1.64M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |